Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 31, 2023

BUY
$47.3 - $70.6 $300,165 - $448,027
6,346 Added 12.89%
55,579 $2.68 Million
Q1 2023

Apr 26, 2023

SELL
$46.97 - $58.27 $375 - $466
-8 Reduced 0.02%
49,233 $2.39 Million
Q4 2022

Feb 09, 2023

BUY
$52.05 - $65.0 $2.56 Million - $3.2 Million
49,241 New
49,241 $2.97 Million
Q2 2022

Aug 02, 2022

SELL
$22.73 - $39.98 $659 - $1,159
-29 Reduced 0.12%
24,016 $652,000
Q1 2022

May 11, 2022

BUY
$30.27 - $49.22 $163,881 - $266,477
5,414 Added 29.06%
24,045 $879,000
Q4 2021

Feb 08, 2022

BUY
$42.11 - $73.26 $183,599 - $319,413
4,360 Added 30.55%
18,631 $920,000
Q3 2021

Nov 09, 2021

BUY
$48.2 - $78.89 $687,862 - $1.13 Million
14,271 New
14,271 $1.02 Million
Q1 2018

Apr 20, 2018

SELL
$27.95 - $45.04 $11.6 Million - $18.7 Million
-416,031 Closed
0 $0
Q4 2017

Jan 25, 2018

BUY
$35.44 - $63.76 $188,292 - $338,756
5,313 Added 1.29%
416,031 $15.6 Million
Q3 2017

Nov 03, 2017

BUY
$53.83 - $67.75 $22.1 Million - $27.8 Million
410,718
410,718 $26.6 Million

Others Institutions Holding PRTA

About PROTHENA CORP PUBLIC LTD CO


  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $701M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Jennison Associates LLC Portfolio

Follow Jennison Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jennison Associates LLC with notifications on news.